SYK
Stryker Corporation
$329.31
장중 · Vol 123.2K · 52주 $281.00–$396.86 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $327.60 · Aug 31, 2026
SYK 가격 추세
종가
$327.60
시가
$327.79
고가
$328.80
저가
$325.43
30초 브리핑
SYK 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 42%
52주 범위 중간 구간으로 가격 위치만으로 방향성은 제한적입니다.
Forward P/E 19.7배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 1.6배
평소보다 거래가 활발해 가격 움직임의 확인 강도가 높습니다.
2026-10-29
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Aug 31, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
SYK 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Aug 31, 2026
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
1941 Stryker Way · Portage, MI, United States · 직원 56,000명
시가총액
$126.84B
Trailing P/E
34.2
최근 12개월 이익 기준
Forward P/E
19.7
이익 증가 기대 반영
EPS (TTM)
$9.66
배당 수익률
1.06%
배당성향
36.1%
베타
0.77
시장보다 방어적
ROE
16.5%
P/B
5.29
EV/EBITDA
18.8
52주 범위
$281.00 – $396.86
현재 위치 42%
거래량
2.42M
20일 평균 1.52M · 1.6배
애널리스트 의견
매수 79%
총 28명 · 0m
DITM LEAPS Analysis
SYK 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK280121C00220000 | 1/21/28 · 1.4Y | $220.00 | $115.30 | 2.5x | 0.8873 | 10.0% | 3.12% | 38.70% | 1 | 76.44 | |
| SYK280121C00240000 | 1/21/28 · 1.4Y | $240.00 | $95.25 | 3.0x | 0.8695 | 12.0% | 4.72% | 33.06% | 0 | 74.82 | |
| SYK280121C00230000 | 1/21/28 · 1.4Y | $230.00 | $115.95 | 2.4x | 0.8434 | 19.1% | 3.54% | 46.86% | 1 | 64.66 |
재무제표
SYK 연간 손익·현금흐름·재무상태
매출 성장률
+11.2%
최근 연간 YoY
EPS 성장률
+8.2%
최근 연간 YoY
영업이익률
20.1%
최근 연간
FCF 마진
17.1%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $25.12B+11.2% | $22.59B+10.2% | $20.50B+11.1% | $18.45B |
| 매출총이익 | $16.07B+11.3% | $14.44B+10.6% | $13.06B+12.8% | $11.58B |
| 영업이익 | $5.06B+8.4% | $4.67B+18.9% | $3.92B+26.1% | $3.11B |
| 순이익 | $3.25B+8.5% | $2.99B-5.4% | $3.17B+34.2% | $2.36B |
| 희석 EPS | $8.40+8.2% | $7.76-5.9% | $8.25+33.7% | $6.17 |
| EBITDA | $6.31B+27.5% | $4.95B-2.2% | $5.06B+23.2% | $4.11B |
| 영업현금흐름 | $5.04B+18.9% | $4.24B+14.3% | $3.71B+41.4% | $2.62B |
| 잉여현금흐름 | $4.28B+22.8% | $3.49B+11.2% | $3.14B+54.0% | $2.04B |
| 총자산 | $47.84B+11.3% | $42.97B+7.7% | $39.91B+8.2% | $36.88B |
| 총부채 | $15.86B+16.6% | $13.60B+4.6% | $12.99B-0.4% | $13.05B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
SYK 실적·배당 일정
매출 하단
$6.59B
EPS 하단
$3.44
매출 상단
$6.76B
배당 지급일
2026-10-30
D-59
실적 발표일
2026-10-29
D-58
EPS 상단
$3.80
매출 컨센서스
$6.69B
EPS 컨센서스
$3.59
배당락일
2026-09-30
D-29
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jun 30, 2026 | $0.8800 |
| Mar 31, 2026 | $0.8800 |
| Dec 31, 2025 | $0.8800 |
| Sep 30, 2025 | $0.8400 |
| Jun 30, 2025 | $0.8400 |
| Mar 31, 2025 | $0.8400 |
| Dec 31, 2024 | $0.8400 |
| Sep 30, 2024 | $0.8000 |
뉴스
SYK 관련 최신 기사
일반PBH vs. SYK: Which Stock Is the Better Value Option?
PBH vs. SYK: Which Stock Is the Better Value Option?
Zacks · Aug 28, 2026
일반Can ISRG Stock Defend Its $131B Valuation?
This is a market-broadening year for Intuitive Surgical. The company is expanding beyond its core da Vinci systems to serve a wider continuum of hospitals and surgery centers.
Trefis · Aug 28, 2026
- 제품·기술
Has BSX Stock Fallen Far Enough To Buy?
U.S. electrophysiology growth slowed sharply and standalone WATCHMAN referrals declined in the same window, leaving the rest of Boston Scientific unable to maintain its growth-stock multiple.
Trefis · Aug 27, 2026
일반2 Cash-Producing Stocks to Target This Week and 1 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
StockStory · Aug 27, 2026
제품·기술Boston Scientific Hammered After Cyberattack Tampers With Shipments
Boston Scientific stock crumbled Wednesday after the company said a cybersecurity incident interrupted processing and shipping.
Investor's Business Daily · Aug 26, 2026
제품·기술Time To Squeeze 14% Yield Out Of Battered BSX Stock?
For long-suffering owners of Boston Scientific, here’s how to get paid a meaningful cash income now, yours to keep no matter what, in exchange for capping your gains at a higher price.
Trefis · Aug 26, 2026
실적Boston Scientific Stock Drops After Cyberattack
Shares of medical-device maker Boston Scientific are down 4.5% Wednesday on concerns that a cyber-attack against the company could hurt near-term revenue. The incident, which Boston Scientific said it detected Tuesday, caused a network outage and disruption to operations, including the ability to process and ship orders, a spokeswoman said. Evercore ISI analysts noted that a similar cyberattack against medical-device maker Stryker in March took about three weeks for the company to recover from.
The Wall Street Journal · Aug 26, 2026
일반Do Options Traders Know Something About Stryker Stock We Don't?
Investors need to pay close attention to SYK stock based on the movements in the options market lately.
Zacks · Aug 26, 2026
제품·기술Boston Scientific hit by cyberattack, global operations affected
Aug 26 (Reuters) - Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders.
Reuters · Aug 26, 2026
제품·기술The Floor Under BSX Stock Is Being Tested Again
Boston Scientific is back on familiar ground, but the business arriving this time is not the same. Will a history of strong bounces matter more than a future of weaker growth.
Trefis · Aug 25, 2026
홀더
SYK 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
82.8%
기관 보유 (유동주식)
87.4%
내부자 보유
5.4%
기관 수
3,044
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 27.41M | $9.07B | 7.1% | -0.7% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 22.54M | $7.45B | 5.9% | 0.7% | Jun 30, 2026 |
| JPMORGAN CHASE & CO | 17.26M | $5.71B | 4.5% | 10.7% | Jun 30, 2026 |
| State Street Corporation | 15.53M | $5.14B | 4.0% | 1.2% | Jun 30, 2026 |
| Greenleaf Trust | 15.23M | $5.04B | 4.0% | -4.4% | Jun 30, 2026 |
| Price (T.Rowe) Associates Inc | 11.92M | $3.94B | 3.1% | 18.7% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 8.17M | $2.70B | 2.1% | -1.9% | Jun 30, 2026 |
| Wellington Management Group, LLP | 8.17M | $2.70B | 2.1% | 0.6% | Jun 30, 2026 |
| Geode Capital Management, LLC | 7.82M | $2.59B | 2.0% | 0.9% | Jun 30, 2026 |
| Morgan Stanley | 5.96M | $1.97B | 1.6% | -5.3% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.